Contents

Current Pharmaceutical Design, Volume 20 - Number 40

Editorial

Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)

, 20(40): 6215 - 6219

Vasilios G. Athyros, Konstantinos Tziomalos, Niki Katsiki and Dimitri P. Mikhailidis


DOI: 10.2174/1381612820666140622201940




Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options

, 20(40): 6220 - 6229

Ioanna Gouni-Berthold and Heiner K. Berthold


DOI: 10.2174/1381612820666140620125213




HDL Genetic Defects

, 20(40): 6230 - 6237

Devaki R Nair, Arun Nair and Anjly Jain


DOI: 10.2174/1381612820666140620122412




Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol

, 20(40): 6238 - 6248

Claudia Stefanutti, Giancarlo Labbadia and Vasilios G. Athyros


DOI: 10.2174/1381612820666140620120130




LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options

, 20(40): 6249 - 6255

Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo and Ron C. Hoogeveen


DOI: 10.2174/1381612820666140620154014




Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL

, 20(40): 6256 - 6269

Constantinos C. Tellis and Alexandros D. Tselepis


DOI: 10.2174/1381612820666140622200916




Dyslipidaemia Related to Insulin Resistance and Cardiovascular Disease in South Asian and West African Populations

, 20(40): 6270 - 6275

Mfon Ewang-Emukowhate, Dilinika Perera and Anthony S. Wierzbicki DM


DOI: 10.2174/1381612820666140620114948




Alcohol and the Cardiovascular System: A Double-Edged Sword

, 20(40): 6276 - 6288

Niki Katsiki, Konstantinos Tziomalos and Dimitri P. Mikhailidis


DOI: 10.2174/1381612820666140620125741




Apolipoprotein B and Apolipopotein A-I in Vascular Risk Prediction-A Review

, 20(40): 6289 - 6298

C. Schmidt and G. Bergstrom


DOI: 10.2174/1381612820666140620121828




Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease

, 20(40): 6299 - 6305

Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis and Dimitri P. Mikhailidis


DOI: 10.2174/1381612820666140620115756




Effects of Lipid-Lowering Agents on Inflammation, Haemostasis and Blood Pressure

, 20(40): 6306 - 6313

Konstantinos Tziomalos, Asterios Karagiannis and Vasilios G. Athyros


DOI: 10.2174/1381612820666140622201452




Statin Treatment Non-adherence and Discontinuation: Clinical Implications and Potential Solutions

, 20(40): 6314 - 6324

Kim Phan, Yessica-Haydee Gomez, Laura Elbaz and Stella S. Daskalopoulou


DOI: 10.2174/1381612820666140620162629




Medications not Intended for Treatment of Dyslipidemias and with a Variable Effect on Lipids

, 20(40): 6325 - 6338

Thomas F. Whayne Jr and Debabrata Mukherjee


DOI: 10.2174/1381612820666140620163023




Halting Arterial Aging in Patients with Cardiovascular Disease: Hypolipidemic and Antihypertensive Therapy

, 20(40): 6339 - 6349

Vasilios Papademetriou, Niki Katsiki, Michael Doumas and Charles Faselis


DOI: 10.2174/1381612820666140620162157




Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all

, 20(40): 6350 - 6357

Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis and Dimitri P. Mikhailidis


DOI: 10.2174/1381612820666140620154545




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science